Search only items with full text availability
Current filters:

Clear current filters  or Add more filters

View Option

Results 1-10 of 26 (Search time: 0.004 seconds).

  Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia (Journal article)

  The Antiplatelet and Antithrombotic Actions of Statins (Journal article)

  Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative study (Journal article)

  The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease (Journal article)

  The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment (Journal article)

  Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes (Journal article)

  Clinical significance of the atorvastatin-clopidogrel drug-drug interaction - Response (Journal article)

  Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB (Journal article)

  Synthetic peptide-analogues of the GPIIb subunit inhibit fibrinogen binding to the GPIIb/IIIa receptor and platelet activation (Journal article)